Fibrosis, The Failing Heart, and Endotrophin | Nordic Bioscience
Cancer Research | The Extracellular Matrix in Oncology
Drug Discovery | Biomarkers in Drug Development: Protein Fingerprint | Nordic Bioscience
Webinar | Fibrosis as a Driver of Cancer, Liver, and Heart-related Outcomes
Webinar | Tumor Fibrosis in Cancer: Fibroblast Activities and New Biomarkers
NEJM Evidence Publication in Heart Failure by Nordic Bioscience and Collaborators
Osteoarthritis | Serum Biomarkers | ARGS
Pulmonary Fibrosis | Translational Biomarkers | PRO-C6
Protein Quantification: The right epitope of the right protein
Cancer Research | Tumor Fibrosis Biomarkers | Immune Checkpoint Inhibitor Therapy
Cardiovascular Diseases | From Atherosclerosis to Heart Failure (HFpEF)
Heart Failure (HFpEF) | Endotrophin as a Novel Biomarker | PRO-C6
Alzheimer's | Early Detection of Neuron Loss | Tau-C Biomarker
Respiratory Diseases | Idiopathic Pulmonary Fibrosis and COPD | Beyond The Interstitial Matrix
Nordic Bioscience – going from manual to automated pipetting with flowbot® ONE
Webinar | HFpEF and Extracellular Matrix Dysregulation: Novel Treatment Strategies
Webinar | Arthritic Diseases: Fibroblasts and Tissue Destruction
Eosinophilic Esophagitis (EoE) | Differentiating Patients with Blood-based Collagen Biomarkers
Kidney Fibrosis | Turnover of The Interstitial ECM as a Predictor of Adverse Outcomes
Rheumatoid Arthritis and Psoriatic Arthritis | Blood-Based Tissue Profiling
